ImmunoPrecise Antibodies

ImmunoPrecise Antibodies (IPA) is a full-service therapeutic antibody discovery company offering species-independent advanced technologies. IPA is the single-source service provider for the entire antibody discovery value chain. We provide the industry's most comprehensive collection of antibody discovery platforms, combined with state-of-the-art candidate optimization and characterization. This enables us to assist clients from identifying therapeutic targets to preparing for the investigational review of clinical product applications. Services provided to clients include the development of wild-type and humanized mouse and rat monoclonal antibodies, recombinant rabbit monoclonal antibodies, polyclonal antibodies, immunoassays, recombinant protein manufacturing, and advanced solutions addressing challenges faced by clients in antibody-related R&D. Additionally, cryopreservation services are offered for the storage of valuable biomaterials, including hybridoma clones, plasmid constructs, and cell lines. The antibodies generated by ImmunoPrecise have a wide range of therapeutic, diagnostic, and research applications.